- Omega Diagnostics' Andrew Shepherd has agreed to step down as chief executive officer and from the board with immediate effect.

He will remain with the group in the role of global ambassador- life president.

He will be succeeded by Colin King, currently chief operating officer of the group.

David Evans, chairman of Omega, said: "Andrew commands a huge amount of respect both internally and externally and I am hoping that in his new role as global ambassador for the company that respect will make the process of adaptation easier and allow Andrew to help the company deliver on his and the company's vision for CD4 in particular."

At 9:22am: [LON:ODX] Omega Diagnostics Group PLC share price was -2.88p at 17.38p

Story provided by